Deutsche Post AG's DHL Supply Chain has announced an agreement to acquire SDS Rx, a move set to expand its capabilities in life sciences and healthcare logistics. This strategic acquisition will enhance DHL's healthcare logistics portfolio, particularly in delivering integrated, time-critical solutions across the life sciences and healthcare supply chain. With SDS Rx's expertise in processing specialized healthcare deliveries and final-mile logistics services, DHL aims to strengthen its service offerings in long-term care, specialty pharmacies, radiopharmacies, and health system networks. This marks DHL's second healthcare acquisition in 2025, following its earlier purchase of CryoPDP, and aligns with its Strategy 2030 growth agenda.